Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/164_2016_76
Reference145 articles.
1. Albaghdadi M, Gheorghiade M, Pitt B (2011) Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Eur Heart J 32:2626–2633
2. Amazit L, Le Billan F, Kolkhof P, Lamribet K, Viengchareun S, Fay MR et al (2015) Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1. J Biol Chem 290:21876–21889
3. Arhancet GB, Woodard SS, Dietz JD, Garland DJ, Wagner GM, Iyanar K et al (2010a) Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines. J Med Chem 53:4300–4304
4. Arhancet GB, Woodard SS, Iyanar K, Case BL, Woerndle R, Dietz JD et al (2010b) Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists. J Med Chem 53:5970–5978
5. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268–275
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Post-marketing safety of finerenone: a disproportionality analysis of the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-08-21
2. Chronische Niereninsuffizienz bei Typ-2-Diabetes – die stille Bedrohung einer Multisystemerkrankung;Aktuelle Kardiologie;2024-07-31
3. Efficacy and Safety Profile of Finerenone in the Management of Diabetic Nephropathy in Its Early Stages;American Journal of Therapeutics;2024-07-23
4. The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease;Diabetes, Obesity and Metabolism;2024-07-18
5. Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease;Journal of Endocrinology;2024-06-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3